WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Stock Ownership - Who owns Lexicon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexicon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Wendy McDermottSVP Human Resources2026-02-2868,107$1.47
$100.12kSell
Scott M. CoianteSVP Chief Financial Officer2026-02-2854,881$1.47
$80.68kSell
Brian T. CrumSVP General Counsel Secr.2026-02-28105,019$1.47
$154.38kSell
Lisa DefrancescoSVP IR and Corp Comm2026-02-2874,572$1.47
$109.62kSell
Michael ExtonChief Executive Officer2026-02-28204,831$1.47
$301.10kSell
Suma GopinathanSVP Discovery2026-02-2824,338$1.47
$35.78kSell
Craig B. GranowitzSVP Chief Medical Officer2026-02-28109,098$1.47
$160.37kSell
Rachel Yap MartensSVP Partnerships Corp Strat2026-02-2835,826$1.47
$52.66kSell
Raymond DebbaneDirector2026-02-252,000$1.49
$2.98kBuy
Raymond DebbaneDirector2026-02-23100,000$1.47
$147.00kBuy

1 of 2

LXRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXRX insiders and whales buy or sell their stock.

LXRX Shareholders

What type of owners hold Lexicon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Raymond Debbane81.04%360,586,095$786.08MInsider
International Sca Artal71.59%318,557,433$694.46MInsider
Participations Sa Rl Artal69.97%311,336,543$678.71MInsider
Siren LLC7.96%35,402,689$77.18MInsider
Amaury Wittouck7.96%35,402,689$77.18MInsider
Invus Public Equities LP7.96%35,402,689$77.18MInsider
Cv Invus6.80%30,248,505$65.94MInsider
Invus Us Partners LLC1.30%5,782,749$12.61MInsider
Ulys LLC1.25%5,553,292$12.11MInsider
Invus Partners LLC0.97%4,321,214$9.42MInsider

1 of 3

LXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXRX0.03%99.97%Net Buying
SANA0.06%47.63%Net SellingNet Selling
SLBT0.00%0.68%
RIGL0.07%99.93%Net SellingNet Selling
JBIO0.11%30.08%Net Buying
View Top Biotech Stocks

Lexicon Pharmaceuticals Stock Ownership FAQ

Who owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals (NASDAQ: LXRX) is owned by 0.08% institutional shareholders, 259.59% Lexicon Pharmaceuticals insiders, and 0.00% retail investors. Raymond Debbane is the largest individual Lexicon Pharmaceuticals shareholder, owning 360.59M shares representing 81.04% of the company. Raymond Debbane's Lexicon Pharmaceuticals shares are currently valued at $742.81M.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.